Skip to main content
. 2022 Jan 19;40(8):1162–1169. doi: 10.1016/j.vaccine.2022.01.007

Fig. 6.

Fig. 6

ACE2-RBD binding inhibition curves. SC: subcutaneous; IN: intranasal; MIX: simple mixture.